Dr. Elliot David Agin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 849 Boston Post Rd, 200, Milford, CT 06460 Phone: 203-874-1512 Fax: 203-874-3877 |
Dr. John C Katsetos, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 353 Bridgeport Avenue, Milford, CT 06460 Phone: 203-283-3858 Fax: 203-783-1132 |
Dr. Aleflor G Ragaza, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 232 Boston Post Rd, Milford, CT 06460 Phone: 203-876-2179 Fax: 203-876-2369 |
Dr. Vijay Kumar Chhabra, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 849 Boston Post Rd, Suite 100, Milford, CT 06460 Phone: 203-882-9608 |
News Archive
Americans are as afraid of becoming an Alzheimer caregiver as they are of getting the disease itself according to a new Omnibus survey of more than 1,000 adults released today by the Alzheimer's Association.
In his latest Kaiser Health News column, Harold Pollack writes: "This month a key program created by the new health overhaul law, the Pre-Existing Condition Insurance Plan, becomes operational in many states. Over the next 40 months, this high-risk insurance pool will provide $5 billion to cover Americans who face the dual challenges of chronic illness and uninsurance.
"With donor money to fight HIV and AIDS falling, spending in sub-Saharan Africa must be targeted to get the best results," Bjorn Lomborg, director of the Copenhagen Consensus Center, writes in the Guardian's "Poverty Matters" blog, noting, "Sub-Saharan Africa has 10 percent of the world's population but is home to 70 percent of those living with HIV and AIDS."
G20 finance ministers "concluded three days of talks late Saturday with pledges of greater cooperation to avert another financial crisis, leaving uncertain how far they would go in changing their domestic policies in response to international pressures," the Associated Press/Christian Science Monitor reports.
Researchers have found that bowel cancer cells have a mechanism by which they can switch off some key molecules on their surfaces and thus escape being recognised and killed by the immunotherapy agents.
› Verified 7 days ago